WO2016020936A3 - Nouvelle forme posologique pharmaceutique orale de rétention gastrique - Google Patents

Nouvelle forme posologique pharmaceutique orale de rétention gastrique Download PDF

Info

Publication number
WO2016020936A3
WO2016020936A3 PCT/IN2015/050070 IN2015050070W WO2016020936A3 WO 2016020936 A3 WO2016020936 A3 WO 2016020936A3 IN 2015050070 W IN2015050070 W IN 2015050070W WO 2016020936 A3 WO2016020936 A3 WO 2016020936A3
Authority
WO
WIPO (PCT)
Prior art keywords
dosage form
same
pharmaceutical dosage
different
novel oral
Prior art date
Application number
PCT/IN2015/050070
Other languages
English (en)
Other versions
WO2016020936A2 (fr
Inventor
Jayendrakumar Dasharathlal PATEL
Shwetaben Dasharathlal PATEL
Original Assignee
Patel Jayendrakumar Dasharathlal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patel Jayendrakumar Dasharathlal filed Critical Patel Jayendrakumar Dasharathlal
Publication of WO2016020936A2 publication Critical patent/WO2016020936A2/fr
Publication of WO2016020936A3 publication Critical patent/WO2016020936A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne une nouvelle forme posologique pharmaceutique orale de rétention gastrique et des procédés de préparation d'une nouvelle forme posologique pharmaceutique orale de rétention gastrique. La présente invention concerne également une nouvelle forme posologique de rétention gastrique qui administre une ou plusieurs substances actives à la même vitesse de libération ou à une vitesse différente par des mécanismes de libération identiques ou différents pendant des périodes de temps identiques ou différentes dans des régions du tractus gastro-intestinal identiques ou différentes à partir d'un seul système d'administration de médicament, c'est-à-dire une forme posologique qui est relativement souple quant au mode d'obtention d'un modèle de libération désiré de substances actives identiques ou différentes.
PCT/IN2015/050070 2014-07-21 2015-07-21 Nouvelle forme posologique pharmaceutique orale de rétention gastrique WO2016020936A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2338/MUM/2014 2014-07-21
IN2338MU2014 2014-07-21

Publications (2)

Publication Number Publication Date
WO2016020936A2 WO2016020936A2 (fr) 2016-02-11
WO2016020936A3 true WO2016020936A3 (fr) 2016-05-26

Family

ID=55264729

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2015/050070 WO2016020936A2 (fr) 2014-07-21 2015-07-21 Nouvelle forme posologique pharmaceutique orale de rétention gastrique

Country Status (1)

Country Link
WO (1) WO2016020936A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106309404B (zh) * 2016-10-27 2019-10-25 四川省百草生物药业有限公司 一种高稳定性的盐酸舍曲林胶囊及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001113A1 (fr) * 1997-07-01 1999-01-14 Pfizer Products Inc. Formes posologiques de sertraline, en solution et encapsulees dans de la gelatine
WO2001047498A2 (fr) * 1999-12-23 2001-07-05 Pfizer Products Inc. Forme de dosage d'un medicament stratifie entraine par un hydrogel
US6517866B1 (en) * 1997-07-01 2003-02-11 Pfizer Inc. Sertraline salts and sustained-release dosage forms of sertraline
WO2006072878A1 (fr) * 2005-01-07 2006-07-13 Ranbaxy Laboratories Limited Formes posologiques orales de sertraline possedant une taille de particule controlee, et leurs procedes de preparation
US20060257475A1 (en) * 2006-08-17 2006-11-16 Boehringer Ingelheim International Gmbh Stable Sertraline Hydrochloride Formulation and Method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001113A1 (fr) * 1997-07-01 1999-01-14 Pfizer Products Inc. Formes posologiques de sertraline, en solution et encapsulees dans de la gelatine
US6517866B1 (en) * 1997-07-01 2003-02-11 Pfizer Inc. Sertraline salts and sustained-release dosage forms of sertraline
WO2001047498A2 (fr) * 1999-12-23 2001-07-05 Pfizer Products Inc. Forme de dosage d'un medicament stratifie entraine par un hydrogel
WO2006072878A1 (fr) * 2005-01-07 2006-07-13 Ranbaxy Laboratories Limited Formes posologiques orales de sertraline possedant une taille de particule controlee, et leurs procedes de preparation
US20060257475A1 (en) * 2006-08-17 2006-11-16 Boehringer Ingelheim International Gmbh Stable Sertraline Hydrochloride Formulation and Method

Also Published As

Publication number Publication date
WO2016020936A2 (fr) 2016-02-11

Similar Documents

Publication Publication Date Title
IL258464A (en) Pharmaceutical compositions for oral administration of peptide drugs
IL251462A0 (en) Pharmaceutical formulations for oral administration of peptide or protein drugs
IL275220A (en) Oral administration of active drug substances
WO2017091749A8 (fr) Dispositifs d'administration de médicaments à changement de forme et procédés
PH12017502431A1 (en) Pharmaceutical formulations comprising tenofovir and emtrictabine
JP2015057451A5 (fr)
MX354210B (es) Formas farmaceuticas orales de liberacion controlada de farmacos escasamente solubles y los usos de estas.
EP3498264A4 (fr) Préparation pharmaceutique pour administration orale à vitesse de dissolution contrôlée, la préparation comprenant des pastilles à libération prolongée contenant du chlorhydrate de tamsulosine
MX2017003561A (es) Composiciones y metodos para revestimientos cannabinoides para su uso en la administracion de farmacos.
PL3793534T3 (pl) Tabletka doustna do dostarczania składników czynnych do przewodu żołądkowo-jelitowego
PH12015500823A1 (en) Modified release formulations for oprozomib
MA39765A (fr) Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
MX2018012618A (es) Composiciones farmaceuticas orales de mesalazina.
CR20140358A (es) Sistema para la administración de fármacos
MX353623B (es) Sistema de suministro de farmaco.
WO2015125152A3 (fr) Compositions pharmaceutiques d'asénapine
MX2017013950A (es) Polvos de zolmitriptán para suministro pulmonar.
WO2016015798A9 (fr) Composition de film orodispersible, comprenant de l'énalapril pour le traitement de l'hypertension dans une population pédiatrique
WO2015001541A3 (fr) Composition de film pharmaceutique
WO2016020936A3 (fr) Nouvelle forme posologique pharmaceutique orale de rétention gastrique
MX2018011685A (es) Proceso para formulaciones solidas de mesalazina.
IN2014MU00043A (fr)
EP3634507A4 (fr) Plates-formes d'administration de médicament prolongée par voie orale
PH12016502540A1 (en) Pharmaceutical dosage forms
UY37413A (es) Formulaciones de liberación inmediata de oprozomib

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15830135

Country of ref document: EP

Kind code of ref document: A2